Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,254
Closed -$758K 824
2024
Q2
$758K Sell
8,254
-18
-0.2% -$1.67K 0.09% 270
2024
Q1
$762K Sell
8,272
-12,783
-61% -$1.2M 0.08% 272
2023
Q4
$2M Buy
+21,055
New +$1.97M 0.23% 127

Other funds holding AMED

Hilltop Holdings's AMED Position: Q3 2024 in Review

Hilltop Holdings sold out of Amedisys (AMED) in Q3 2024, closing a stake of 8,254 shares — an estimated $758K sold.

Hilltop Holdings first reported a position in AMED in Q4 2023 and held it in 3 quarters. The position peaked at $2M in Q4 2023. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Hilltop Holdings reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Hilltop Holdings sold 8,254 Amedisys shares in Q3 2024, an estimated $758K.
  • Hilltop Holdings first reported a position in Amedisys in Q4 2023 and held it in 3 quarters.
  • Hilltop Holdings's Amedisys position peaked at $2M in Q4 2023.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Hilltop Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.